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Abstract
Purpose: Measurement error is an important source of bias in epidemiological studies.
We illustrate three approaches to sensitivity analysis for the effect of measurement error:
imputation of the ‘true’ exposure based on specifying the sensitivity and specificity of the
measured exposure (SS); direct imputation (DI) using a regression model for the predict-
ive values; and adjustment based on a fully Bayesian analysis.
Methods: We deliberately misclassify smoking status in data from a case-control study
of lung cancer. We then implement the SS and DI methods using fixed-parameter (FBA)
and probabilistic (PBA) bias analyses, and Bayesian analysis using the Markov-Chain
Monte-Carlo program WinBUGS to show how well each recovers the original
association.
Results: The ‘true’ smoking-lung cancer odds ratio (OR), adjusted for sex in the original
dataset, was OR¼8.18 [95% confidence limits (CL): 5.86, 11.43]; after misclassification,
it decreased to OR¼3.08 (nominal 95% CL: 2.40, 3.96). The adjusted point estimates
from all three approaches were always closer to the ‘true’ OR than the OR estimated
from the unadjusted misclassified smoking data, and the adjusted interval estimates
were always wider than the unadjusted interval estimate. When imputed misclassifica-
tion parameters departed much from the actual misclassification, the ‘true’ OR was
often omitted in the FBA intervals whereas it was always included in the PBA and
Bayesian intervals.
VC The Author 2017; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 1
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Conclusions: These results illustrate how PBA and Bayesian analyses can be used to bet-
ter account for uncertainty and bias due to measurement error.
Key words: Misclassification, lung cancer, smoking status, sensitivity/specificity imputation, direct imputation, fully
Bayesian analysis
Introduction
A major source of bias and uncertainty in epidemiological
analysis is measurement error, usually termed ‘misclassifica-
tion’ when referring to discrete variables.1–4 Measurement
error can be considered a missing-data problem3 in that in-
formation has been recorded on a variable which is an im-
perfect surrogate for the missing ‘true’ variable of interest.
When internal validation or replication data are not
available, the true values for the mismeasured variables are
completely missing and no consistent point estimate can be
constructed from the data without adding further, poten-
tially arbitrary assumptions. To address this problem, sim-
ple sensitivity-analysis formulae adjust for misclassification
assuming various values for fixed misclassification rates,
based on background literature or on external validation
data.2,13,14 More sophisticated analyses construct and use
prior distributions for these rates;2–4,13,15–18 in that case,
standard missing-data software can be used by augmenting
the actual data with pseudo-validation data representing
these priors.3. Such analyses may be repeated using differ-
ent plausible priors to assess sensitivity to the assumed prior
information.
In this paper we focus on the situation where exposure
has been misclassified, no validation data are available and
adjustment for potential confounders or matching factors
is needed. We illustrate and compare methods to adjust for
the misclassification of smoking status in a case-control
study of smoking and lung cancer, while also adjusting for
sex. Each method can be carried out with commercial
software.
Material and Methods
Methods
In a case-control study, let Y, T and C denote the outcome
(case/control status), exposure status (exposed/unexposed) and
a dichotomous covariate, respectively. In many studies the ex-
posure T cannot be directly observed and a surrogate exposure
X is measured instead. In order to retrieve information on the
‘true’ exposure and its association with the outcome, one has
to make a priori assumptions on the relationship between T
and X, i.e. on the misclassification rates. Assumptions can be
made on one of the two following groups of rates:
i. In the sensitivity-specificity imputation approach (SS),
assumptions are made on the proportion of subjects
classified as exposed among those truly exposed, i.e.
the sensitivity (Se) and the proportion of subjects classi-
fied as unexposed among those truly unexposed, i.e. the
specificity (Sp).
ii. In the direct imputation approach (DI), assumptions
are made on the proportion of truly exposed subjects
among those classified as exposed, i.e. the positive pre-
dictive value (PPV), and the proportion of truly unex-
posed subjects among those classified as unexposed, i.e.
the negative predictive value (NPV). The predictive
Key messages
• We illustrate how to apply several methods for sensitivity analysis of misclassification, including imputation based on
sensitivity and specificity, direct imputation based on predictive values and fully Bayesian analyses.
• Sensitivity-specificity imputation requires only values or prior distributions for sensitivity and specificity, but these
values or priors should be restricted to values compatible with the data.
• Direct imputation does not require range restrictions, but does require information beyond sensitivity and specificity,
such as a prior distribution for the association of interest.
• Fully Bayesian analyses require the most prior information, but can best capture the uncertainty warranted under the
assumed models and priors.
• All methods should employ priors that are plausible in light of background literature.
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values can be expressed as functions of the sensitivity,
specificity and true exposure prevalence:
PPV ¼ Se PðT ¼ 1Þ
Se PðT ¼ 1Þ þ ð1  SpÞ 

1  PðT ¼ 1Þ

NPV ¼
Sp

1  PðT ¼ 1Þ

Sp

1  PðT ¼ 1Þ

þ ð1  SeÞ  PðT ¼ 1Þ
Making assumptions about PPV and NPV is therefore
equivalent to making assumptions on Se, Sp and P(T¼ 1).
Figure 1 summarizes how information from a priori as-
sumptions and information from the data are combined to
provide adjusted estimates in both methods. Detailed algo-
rithms are included in Appendix A (available as
Supplementary data at IJE online).
These assumptions can be expressed with more or less
uncertainty. One can define a range of a priori values for
the misclassification proportions (fixed-parameter-bias-
sensitivity analysis or FBA) or a priori probability distribu-
tions for these proportions (probabilistic bias analysis or
PBA). The most rigorous way to do PBA is via Bayesian
techniques,15 but a simple approximation is provided by
Monte Carlo sensitivity analysis (MCSA) in which combin-
ations of parameters are sampled from the prior distribu-
tions, and then an analysis is conducted for each sampled
combination.2,13,16,17 Thus, MCSA involves a sensitivity
analysis using a random sample of values for adjustments,
instead of fixed values. On the other hand, a fully Bayesian
analysis updates the prior distributions based on the study
data to yield posterior distributions for the param-
eters.2,13,16,17 Procedures for MCSA have been imple-
mented in Excel and SAS.2,16
We consider here both SS and DI approaches, using
FBA, MCSA and a fully Bayesian analysis. The a priori val-
ues and distributions are described in Table 1.
We use updated versions of a SAS macro implementing
MCSA, which allow covariates in the imputation model,16
and the free software WinBUGS to implement fully
Bayesian analysis.
We caution that the interval estimates used for our ana-
lyses do not satisfy the criterion for being valid confidence
intervals (they would not have 95% coverage under all
fixed parameter values); although they may provide ad-
equate coverage when the true parameter values are very
close to the parameter values used in the FBA, or close to
the centres of the prior distributions in the MCSA, they
can have poor coverage otherwise. Neither are the FBA
and MCSA intervals valid posterior intervals (they are not
a coherent integration of prior and data information) al-
though MCSA intervals can be adequate approximations
under certain simplifying assumptions.15,17 We therefore
refer to them only as FBA or MCSA intervals, as appropri-
ate, noting that the quality of the MCSA approximation to
Figure 1. Steps of sensitivity/specificity imputation analysis (SS) and direct imputation analysis (DI).
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Bayesian results is adequate to the extent that the distribu-
tion of sampled parameters would be negligibly updated
by a fully Bayesian analysis.
Description of the data and misclassification
The data are from a population-based lung cancer case-
control study conducted in New Zealand.19 Briefly, cases
were all subjects diagnosed with incident lung cancer noti-
fied to the New Zealand Cancer Registry during 2007 and
2008 and aged 20–75 years. Controls were recruited from
the New Zealand Electoral Rolls of 2003 and 2008 and
were frequency matched with the cases for age and sex.
For further details see Corbin et al.19
We considered the association between smoking status
(ever/never) and lung cancer. The odds ratio (OR) of lung
cancer for being ever-smoker vs never-smoker was estimated
using unconditional logistic regression, adjusting for sex.
The SAS logistic procedure (SAS V9.3) was used to estimate
ORs and corresponding 95% confidence intervals (95% CI).
To provide a hypothetical reference point for evalu-
ations, we assumed that our original dataset was correctly
specified, i.e. that the ‘true’ smoking status indicator T was
known for all subjects. We then deliberately misclassified T
to X, and pretended that this was our observed measure.
We attempted to use realistic misclassification rates which
had been observed in previous studies. In nine studies using
the cotinine validation method reported by a meta-ana-
lysis,20 the lowest sensitivity of the self-reported smoking
status was 0.82 and the lowest specificity was 0.91. We
therefore took the original data, then misclassified T with a
sensitivity of 0.8 and a specificity of 0.9. The misclassifica-
tion was applied nondifferentially, i.e. independently of the
other variables (disease status, sex). In case-control studies,
the nondifferential misclassification assumption may not
hold, because cases and controls may report past behaviour
differently, but the methods applied here can be extended to
situations where misclassification is differential.2, 3, 16, 17
Let Y, C and X denote the indicators for case-control
status, sex (1¼Man, 0¼Woman) and misclassified smok-
ing status, respectively, and let ntycx denote the number of
subjects with T¼ t, Y¼ y, C¼ c and X¼ x. To create the
misclassified smoking status X, we computed the frequen-
cies ntycþ in each of the eight combinations of the catego-
ries of T, Y and C, where a subscript ‘þ’ indicates
summation over a subscript. We then calculated the fre-
quencies of classified ever/never smokers ntycx for each of
these combinations as follows:
n1yc1 ¼ n1ycþ  0:8
n1yc0 ¼ n1ycþ  0:2
n0yc1 ¼ n0ycþ  0:1
n0yc0 ¼ n0ycþ  0:9:
A preliminary analysis was conducted in order to check
what possible values of sensitivity and specificity could
have led to the misclassified odds ratio.23 Let pYC be the
proportion of subjects truly ever-smokers and pYC the
proportion of subjects classified as ever-smokers in the dif-
ferent strata of Y and C. Then:
pYC¼ pYC
 þ Sp 1
Seþ Sp 1
The proportions pYC must fall in the range from 0 to 1,
which implies the following restrictions:
If seþ sp>1
Se > maxYCðpYCÞ and Sp > maxYCð1  pYCÞ
If Seþ Sp< 1
Se < minYCðpYCÞ and Sp < minYCð1  pYCÞ
Table 2 shows the proportions of subjects classified as
ever-smokers pYC and never-smokers 1pYC in strata of
Y and C. The restrictions on Se and Sp become:
If Seþ Sp> 1
Se > p11 ði:e: Se > 0:76Þ and Sp > 1  p00 ði:e: Sp > 0:59Þ
If Seþ Sp< 1
Se < p00 ði:e: Se < 0:41Þ and Sp < 1  p11 ði:e: Sp < 0:24Þ
As we assumed that self-reported smoking status was
classified better than chance, we only considered the case
where Se þ Sp> 1.
Results
The ‘true’ odds ratio of lung cancer for ever-smokers vs
never-smokers adjusted for sex in the original dataset was
Table 2. Prevalences of subjects classified as exposed and
non-exposed in strata of Y and C
Y C pYC 1pYC
0 0 0.41 0.59
0 1 0.52 0.48
1 0 0.69 0.31
1 1 0.76 0.24
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OR¼ 8.18 (95% CL: 5.86, 11.43) [log odds ratio (ln
OR)¼ 2.10, (95% CL: 1.77, 2.44)]. After misclassifying
the smoking status with a sensitivity of 0.8 and a specificity
of 0.9, the estimated OR was 3.08 (95% CL: 2.40, 3.96)
[ln OR¼ 1.13 (95% CL: 0.87, 1.38)]. Tables 3 and 4 give
the results obtained with the different methods using fixed-
parameter and probabilistic bias analyses, respectively.
When assuming sensitivity values (Se0) between 0.7 and
0.9 and specificity values (Sp0) between 0.8 and 1, SS FBA
produced adjusted ORs ranging from 3.96 to 15.67 and DI
FBA produced adjusted ORs between 3.88 and 17.72.
Lower 95% SS and DI FBA limits went down to 2.84 and
2.97, respectively, whereas upper SS and DI FBA limits
went up to 44.60 and 26.30, respectively.
As expected, for larger values of Se0 and Sp0, the OR
obtained with SS FBA became closer to the OR obtained
with the misclassified smoking status. The OR estimate ap-
peared more sensitive to changes in the sensitivity than in
the specificity of the measured exposure. When Se0 was
0.7, the sensitivity was replaced by 0.77 in step (ii) of the
algorithm (see Appendix A).
Similarly, DI FBA produced adjusted ORs closer to the
OR obtained with the misclassified smoking status when
we assumed higher sensitivity and specificity. However,
the adjusted OR was more sensitive to the value given to
the OR of lung cancer in women ORTY(C¼ 0) than to the
values given to the sensitivity and specificity. When the val-
ues given to the sensitivity and the specificity were equal to
the actual sensitivity and specificity of the introduced mis-
classification (Se¼ 0.8, Sp¼ 0.9), the OR obtained with DI
FBA was very close to the value given to ORTY(C¼0).
Both the SS FBA and DI FBA interval estimates ob-
tained after adjustment were wider on the logarithmic scale
than the intervals obtained with the ‘standard’ analysis
using misclassified smoking status. The intervals became
narrower when increasing the sensitivity and specificity
and when decreasing ORTY(C¼ 0) for DI FBA. The inter-
vals were wider when using SS FBA than when using DI
FBA, as SS FBA also attempted to account for the uncer-
tainty in estimating the prevalence of subjects classified as
ever-smokers p.
When assuming 95% prior limits of 0.68 and 0.90 for
the sensitivity, of 0.80 and 0.96 for the specificity and an
average for ORTY(C¼ 0) of 6.93, 95% of the odds ratios
from SS PBA were between 2.99 and 23.17; whereas 95%
from Bayesian analysis 1 (Table 1) were between 4.44 and
48.51. Using DI PBA, 95% of the odds ratios were between
3.06 and 26.07; whereas from Bayesian analysis 2, 95%
were between 4.23 and 21.78. As expected, prior means
for the sensitivity and the specificity equal to the actual
misclassification sensitivity and specificity gave the closest
median ORs to the ‘true’ OR. Ta
b
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In SS PBA, out of 10 000 draws of initial sensitivity Se0,
8,799 (88%), 3128 (31%), 4283 (43%) and 76 (0.76%)
values for prior distributions 1, 2, 3 and 4, respectively,
were lower or equal to 0.76 and were adjusted to 0.77. In
draws of initial specificity Sp0 from prior distribution 3,
415 (4%) were lower or equal to 0.59 and were adjusted
to 0.60. An increase of the prior means for the sensitivity
and specificity resulted in a decrease of the median ORs.
When expanding the 95% limits for the sensitivity and spe-
cificity, the median ORs increased slightly, moving away
from the ‘true’ OR, and the 95% simulation intervals
(95% SI) were much wider. For DI PBA, as for DI FBA, an
increase in the prior means for the sensitivity and the speci-
ficity still resulted in a decrease of the median ORs;
whereas increasing the prior mean for ORTY(C¼ 0) con-
siderably increased the median ORs. Expanding the 95%
limits for the sensitivity and the specificity slightly
increased the median ORs and the 95% SI. Both SS and DI
MCSA intervals were much wider than the interval esti-
mates obtained with the original and the misclassified
smoking status.
As with SS PBA, median ORs obtained from fully
Bayesian analysis 1 decreased when increasing the sensitiv-
ity and the specificity. However, median ORs obtained
from Bayesian analysis 1 were higher than median ORs ob-
tained with SS PBA; 95% credibility intervals (95% CI) ob-
tained from Bayesian analysis 1 were also wider than the
95% SI obtained with SS PBA, suggesting that SS PBA
underestimates the uncertainty in the prevalence of true
smokers in strata of T and Y.
In comparison with median ORs obtained from DI
PBA, median ORs obtained from Bayesian analysis 2 were
more sensitive to the prior means assigned to the sensitivity
and specificity and less sensitive to the prior mean assigned
to ORTY(C¼ 0). Credibility intervals (95% CI) obtained
from Bayesian analysis 2 were slightly narrower than DI
PBA 95% SI.
When the means assigned to sensitivity and specificity
equalled the actual misclassification sensitivity and specifi-
city, the informative prior distributions used in Bayesian
analysis 2 yielded median ORs closer to the ‘true’ OR than
in Bayesian analysis 1. Credibility intervals were narrower
after Bayesian analysis 2 than after Bayesian analysis 1.
Discussion
We have illustrated the use of several currently available
methods for bias analysis which can be implemented using
standard statistical software. Sensitivity/specificity (SS) im-
putation analysis has the advantage of requiring only the
specification of a priori values for sensitivities and specific-
ities. When one wishes to account for uncertainty about
these values, one can specify prior distributions for the val-
ues and then sample from those.2,13,17
Nonetheless, the apparent simplicity of the SS approach
has its own difficulties, since seemingly intuitive guesses for
sensitivity and specificity may turn out to be highly implaus-
ible when compared with what one might deduce by con-
sidering the actual classification mechanism and background
literature, particularly when covariates are also taken into
account. Furthermore, prior distributions for sensitivity and
specificity in PBA require restriction to the range of values
compatible with the data (because some values may be im-
possible given the observed data) whereas fully Bayesian
methods automatically accommodate such restrictions.15,17
Direction imputation (DI) analysis directly models pre-
dictive values, thus eliminating the need for constraints
on sensitivity and specificity.3 Its main limitation is that
the user needs to specify values or prior distributions for
coefficients about which there may be poor prior informa-
tion, such as the association of interest (here, the odds
ratio of lung cancer for being ever-smoker), and the re-
sulting adjusted estimate can be very sensitive to that
distribution.
Table 4. Smoking-lung cancer odds ratios from SS PBA, DI PBA and Bayesian analyses 1 and 2; 95% interval estimates in
brackets
Sensitivity 0.70[0.60,0.82] 0.80[0.68,0.90] 0.80[0.54,0.98] 0.90[0.80,0.96]
Specificity 0.80[0.68,0.90] 0.90[0.80,0.96] 0.90[0.59,0.99] 0.99[0.97,1.00]
SS PBA 15.31[4.78,48.20] 8.18[2.99,23.17] 9.05[2.15,63.86] 4.12 [2.64,8.09]
DI PBA (mean ORTY(C5 0)53.5) 4.83[2.11,14.09]
DI PBA (mean ORTY(C5 0)56.93) 9.33[2.89,36.90] 7.45[3.06,26.07] 6.81[2.93,28.26] 5.07[2.92,13.94]
DI PBA (mean ORTY(C5 0)514) 12.59[4.45,52.00]
Bayesian analysis 1 18.5[6.72,86.24] 11.63[4.44,48.51] 12.08[3.60,64.51] 4.75[2.93,18.48]
Bayesian analysis 2 (mean ORTY(C5 0)53.5) 6.70[3.85,15.40]
Bayesian analysis 2 (mean ORTY(C5 0)56.93) 12.10[5.67,35.38] 8.03[4.23,21.78] 7.09[3.28,23.50] 4.47[3.14,8.12]
Bayesian analysis 2 (mean ORTY(C5 0)514) 10.63[4.83,37.09]
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Both SS and DI methods have been applied using fixed-
parameter bias-sensitivity analysis (FBA) and probabilistic
bias-sensitivity analysis (PBA). FBA is simpler and faster to
run, since one only needs to specify fixed values. It is also
very useful to check which values are compatible with the
data in the SS method. Nonetheless, it does not account for
uncertainty in the specification of the bias parameters. PBA
takes this uncertainty into account and as a result produces
wider interval estimates, thus producing inferences less
sensitive to misspecification of the bias parameters.
Rough allowance for uncertainty due to random error
in PBA can be made via the addition of a random number
to estimates during simulation. This shortcut thus leads to
fast run times, but should be used with caution as it may
seriously underestimate the actual contribution of random
error to uncertainty about the TY association; this under-
estimation will be a problem if uncertainty due to random
error is not minor compared with uncertainty about the
classification parameters. Bootstrap or jackknife methods
for adding random error are preferable, but can lead to
long run times; bootstrapping in particular can also en-
counter technical problems in small samples.21
The choice between SS and DI depends on what infor-
mation is available. In particular, one needs to evaluate the
amount and the quality of prior information to decide
between setting priors on sensitivity and specificity or on
regression coefficients for predictive values. When both
validation data and prior information are available, all
the information can be combined using data augmenta-
tion3,24–26 in which prior distributions are translated into
new data records and added to the validation data. Such
an approach enables analysis with standard methods for
missing data.
Bayesian procedures may be preferable to PBA, espe-
cially when one feels comfortable assigning priors to par-
ameters beyond the classification model.15 Our Bayesian
analyses indicated that the uncertainty in the prevalence of
exposure might be underestimated when using SS PBA. In
addition, unlike SS PBA, Bayesian analyses do not require
truncation of the prior distributions when the sensitivity or
specificity prior extends below the range compatible with
the data. For further analysis and contrast of SS PBA and
Bayesian analyses, see Maclehose and Gustafson.15
It has been remarked that most epidemiologists write
their methods and results sections as frequentists and their
introduction and discussion sections as Bayesians.3,27 In
their methods and results sections, they analyse their data
as if those are the only data that exist, and as if there is no
bias left uncontrolled by the study design or by covariate
adjustment (i.e. they implicitly use point-null priors on hid-
den bias parameters3). In the discussion, they then assess
their results relative to background information,
examining consistency with previous studies, biological
plausibility and the possibility of various biases. It has
been lamented, however, that in the latter discussions they
severely overweight their own results, and tend to under-
state biases in these results, displaying especially poor intu-
itions about potential misclassification and measurement-
error effects.2,13,17,28
These problems can be mitigated by including bias ana-
lyses.2,3,13,29 FBA is particularly simple and may be useful
for initial bias analyses, but we recommend PBA or
Bayesian analyses when doing a risk assessment that must
account for all sources of uncertainty. We have reviewed
and illustrated several methods feasible using standard
statistical software. We hope that sensitivity and bias ana-
lyses will become options in standard statistical packages
to supplement existing methods, facilitating their conduct
and presentation before inferences are offered. This will
enable readers to better quantitatively assess the uncer-
tainty warranted in the face of methodological problems.29
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